Auris Medical Holding AG | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$21.8 |
Market Cap |
$5.03 M |
Shares Outstanding |
2.35 M |
Public Float |
24.22 M |
Address |
Clarendon House Hamilton HC HM 11 Bermuda |
Employees | - |
Website | http://www.aurismedical.com |
Updated | 07/08/2019 |
Auris Medical Holding AG engages in the provision of biopharmaceutical business. It focuses on the development of novel products for the treatment of inner ear disorders. It includes tinnitus, haring loss, and meniere's disease. |